OneCell Diagnostics Inc.
India
- Pune , Maharashtra
- 22/11/2024
- Series A
- $16,000,000
OneCell Diagnostics, Inc. is a Precision Oncology Liquid Biopsy Diagnostics Company focused on developing the 1st-in-Class, Circulating Tumor Cell (CTC)-based, Single-Cell Multi-omics Lab Developed Tests for applications in clinical cancer care & early-stage clinical trials for Biotech/Pharma companies.
OneCell Diagnostics, Inc. is a joint venture between two companies with innovative technologies: Actorius Innovations and Research Pvt Ltd, a leading provider of CTC Tests in India, and Indx.ai, a Silicon Valley based innovative software company specialising in Multi-omics Biomarker Data Analytics.
- Industry Biotechnology Research
- Website https://www.onecelldx.com/
- LinkedIn https://www.linkedin.com/company/onecelldx/
Related People
Mohan UttarwarCo Founder
United States -
Cupertino, California
* Serial entrepreneur who co-founded 5 companies, raised over $50M in investment and created the share-holder value of over $500M.
* Strategic thinker who can identify holes in the marketplace and attract a great team to build innovative products & solutions to fill those holes and get the first mover advantage.
* Visionary with a mission of touching the lives of 1B patients and making a societal impact around the world.
* Angel Investor with real world experience of helping entrepreneurs building business & creating value
Barnwell Bio | $6,000,000 | (Jan 27, 2026)
Orbital(US) | $60,000,000 | (Jan 27, 2026)
Inferact | $150,000,000 | (Jan 27, 2026)
Visitt | $22,000,000 | (Jan 27, 2026)
Cashmere(US) | $5,000,000 | (Jan 27, 2026)
Cambio | $18,000,000 | (Jan 23, 2026)
Yuki | $6,000,000 | (Jan 23, 2026)
ZBD | $40,000,000 | (Jan 23, 2026)
Allocation Strategy | $2,164,392 | (Jan 23, 2026)
Mia Labs | $20,000,000 | (Jan 23, 2026)
Mendra | $82,000,000 | (Jan 23, 2026)
Artie Technologies | $12,000,000 | (Jan 23, 2026)